Inhibition of capacitative Ca2+ entry into cells by farnesylcysteine analogs

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1495-1501

  Xu, Yajun ^a   Gilbert, Bryant A ^b   Rando, Robert R ^b   Chen, Longchuan ^a   Tashjian Jr , Armen H ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYSTEINE; DRUG DERIVATIVE; GUANOSINE TRIPHOSPHATE; MANGANESE; THAPSIGARGIN; GUANINE NUCLEOTIDE BINDING PROTEIN;

AFFINITY LABELING; ARTICLE; CELL LINE; HUMAN; METABOLISM; PROTEIN BINDING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; KIDNEY CELL; MEMBRANE PERMEABILITY; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION;

AFFINITY LABELS; CALCIUM; CELL LINE; CYSTEINE; GUANOSINE TRIPHOSPHATE; HUMANS; MANGANESE; PROTEIN BINDING; THAPSIGARGIN;

EID: 0030299896     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Putney, J. W., Jr. Capacitative calcium entry revisited. Cell Calcium 11:611-624 (1990).
2. 2+ influx. Nature (Lond.) 364:809-814 (1993).
3. 2+ entry: toward a proliferation or a simplification? FASEB J. 6:3085-3091 (1992).
4. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol. Sci. 15:77-83 (1994).
5. Fasolato, C., M. Hoth, and R. Penner. A GTP-dependent step in the activation mechanism of capacitative calcium influx. J. Biol. Chem. 268: 20737-20740 (1993).
6. Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature (Lond.) 361:315-325 (1993).
7. + current by means of a phosphatase and a diffus-ible messenger. Nature (Lond.) 364:814-818 (1993).
8. 2+ entry pathway in differentiated HL60 cells. J. Biol. Chem. 269:29451-29456 (1994).
9. 2+ influx. J. Biol. Chem. 269:12645-12653 (1994).
10. Vostal, J. G., W. L. Jackson, and N. R. Shulman. Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J. Biol. Chem. 266:16911-16916 (1991).
11. 2+ entry by tyrosine kinase inhibitors. J. Biol. Chem. 268:9945-9948 (1993).
12. 2+ pool depletion. J. Biol. Chem. 270:26790-26793 (1995).
13. Bird, G. St. J., and J. W. Putney, Jr. Inhibition of thapsigargin-induced calcium entry by microinjected guanine nucleotide analogues. Evidence for the involvement of a small G-protein in capacitative calcium entry. J. Biol Chem. 268:21486-21488 (1993).
14. 2+ influx. J. Biol. Chem. 271:7883-7886 (1996).
15. Casey, P. J., J. F. Moomaw, F. L. Zhang, J. B. Higgins, and J. A. Thissen. Prenylation and G protein signaling. Recent Prog. Horm. Res. 49:215-238 (1994).
16. Ando, S., K. Kaibuchi, T. Sasaki, K. Hiraoka, T. Nishiyama, T. Mizuno, M. Asada, H. Nunoi, I. Matsuda, Y. Matsuura, P. Polakis, F. McCormick, and Y. Takai. Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J. Biol. Chem. 267:25709-25713 (1992).
17. McGeady, P., S. Kuroda, K. Shimizu, Y. Takai, and M. H. Gelb. The farnesyl group of h-ras facilitates the activation of a soluble upstream activator of mitogen-activated protein kinase. J. Biol. Chem. 270:26347-26351 (1995).
18. Sinensky, M., and R. J. Lutz. The prenylation of proteins. Bioessays 14:25-31 (1992).
19. Ma, Y.-T., and R. R. Rando. A microsomal endoprotease that specifically cleaves isoprenylated peptides. Proc. Nati. Acad. Sci. USA 89:6275-6279 (1992).
20. Scheer, A., and P. Gierschik. Farnesylcysteine analogues inhibit chemotactic peptide receptor-mediated G-protein activation in human HL-60 granulocyte membranes. FEBS Lett. 319:110-114 (1993).
21. Ding, J., D. J. Lu, D. Perez-Sala, Y.-T. Ma, J. F. Maddox, B. A. Gilbert, J. A. Badwey, and R. R. Rando. Farnesyl-L-cysteine analogs can inhibit or initiate superoxide release by human neutrophils. J. Biol. Chem. 269: 16837-16844 (1994).
22. Ma, Y.-T., Y. Q. Shi, Y. H. Lim, S. H. McGrail, J. A. Ware, and R. R. Rando. Mechanistic studies on human platelet isoprenylated protein methyltransferase: farnesylcysteine analogs block platelet aggregation without inhibiting the methyltransferase. Biochemistry 33:5414-5420 (1994).
23. Reichlin, S. Somatostatin (first of two parts). N. Engl. J. Med. 309:1495-1501 (1983).
24. Reichlin, S. Somatostatin (second of two parts). N. Engl. J. Med. 309:1556-1563 (1983).
25. 2+], in addition to inhibiting adenylate cyclase, in Proceedings of the 76th Annual Meeting of the Endocrine Society, Endocrine Society Press, Bethesda, MD, 589 (1994).
26. Gusovsky, F., J. E. Lueders, E. C. Kohn, and C. C. Felder. Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma. An alternative mechanism for cholinergic-induced phosphoinositide breakdown. J. Biol. Chem. 268:7768-7772 (1993).
27. Merritt, J. E., W. P. Armstrong, C. D. Benham, T. J. Hallam, R. Jacob, A. Jaxa-Chamiec, B. K. Leigh, S. A. McCarthy, K. E. Moores, and T. J. Rink. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 271:515-522 (1990).
28. Felder, C. C., A. L. Ma, L. A. Liotta, and E. C. Kohn. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J. Pharmacol. Exp. Ther. 257:967-971 (1991).
29. Hupe, D. J., R. Boltz, C. J. Cohen, J. Felix, E. Ham, D. Miller, D. Soderman, and D. Van Skiver. The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582. J. Biol. Chem. 266:10136-10142 (1991).
30. Bruno, J. F., Y. Xu, J. Song, and M. Berelowitz. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc. Natl. Acad. Sci. USA 89:11151-11155 (1992).
31. Tashjian, A. H., Jr. Clonal strains of hormone-producing pituitary cells. Methods Enzymol. 58:527-535 (1979).
32. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
33. 1 cells. Mol. Pharmacol. 46:644-652 (1994).
34. Gilbert, B. A., and R. R. Rando. Modular design of biotinylated photoaffinity probes - synthesis and utilization of a biotinylated pepstatin photoprobe. J. Am. Chem. Soc. 117:8061-8066 (1995).
35. Brown, M. J., P. D. Milano, D. C. Lever, W. W. Epstein, and C. D. Poulter. Prenylated proteins. A convenient synthesis of farnesyl cysteinyl thioethers. J. Am. Chem. Soc. 113:3176-3177 (1991).
36. Gilbert, B. A., E. W. Tan, D. Perez-Sala, and R. R. Rando. Structure-activity studies on the retinal rod outer segment isoprenylated protein methyltransferase. J. Am. Chem. Soc. 114:3966-3973 (1992).
37. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685 (1970).
38. 2+ fluxes. J. Biol. Chem. 259:418-426 (1984).
39. 2+ concentrations in pituitary cells. Relation to prolactin release. J. Biol. Chem. 259:5827-5832 (1984).
40. 2+ exchange. Endocrinology 124:2765-2776 (1989).
41. Hallam, T. J., and T. J. Rink. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett. 186:175-179 (1985).
42. Hori, Y., A. Kikuchi, M. Isomura, M. Katayama, Y. Miura, H. Fujioka, K. Kaibuchi, and Y. Takai. Post-translational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins. Oncogene 6:515-522 (1991).
43. Hall, A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol. 10:31-54 (1994).